Digital Support for Caregivers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effectiveness and usability of an online platform called Altitudes, which offers support and resources for those caring for young people with psychosis. The goal is to determine if this digital community can enhance caregivers' well-being and social support. The trial will also assess how frequently and easily participants use the platform over six months. Parents, caregivers, or supporters of young people with psychosis who have internet access may be suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative support solutions for caregivers.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this digital platform is safe for caregivers?
Research has shown that the Altitudes platform has been tested for caregiver acceptance and usability. Studies have evaluated its ease of use and perceived helpfulness among caregivers. No reports of negative side effects or harm have emerged, as Altitudes is a digital tool, not a medication. This suggests it is a safe option for caregivers seeking support. The platform provides a moderated online space where caregivers can access educational content and connect with others in similar situations.12345
Why are researchers excited about this trial?
Researchers are excited about Altitudes because it offers a digital support platform specifically designed for caregivers of individuals experiencing first-episode psychosis. Unlike traditional support options, which often rely on in-person therapy and support groups, Altitudes provides 24/7 access to educational and therapeutic content online. Additionally, it fosters a moderated community network, allowing caregivers to connect and share experiences at any time. This accessibility and continuous support are what make Altitudes stand out, potentially easing the burden on caregivers who might not have flexible schedules or easy access to conventional support resources.
What evidence suggests that this digital platform is effective for caregivers of young people with psychosis?
Research has shown that family support can reduce relapse rates and shorten hospital stays for people with psychosis. Studies also indicate that these support systems benefit caregivers of young people experiencing their first episode of psychosis by equipping them with better tools and assistance. In this trial, participants will use the digital health tool, Altitudes, which offers quick access to helpful resources and can improve caregivers' well-being. These platforms help caregivers feel more supported and enhance their overall health. Altitudes aims to provide educational and therapeutic content to strengthen the social support available to caregivers.25678
Who Is on the Research Team?
Kelsey R Ludwig, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Diana Perkins, MD, MPH
Principal Investigator
University of North Carolina, Chapel Hill
Are You a Good Fit for This Trial?
This trial is for caregivers and supporters of young people with psychosis in North Carolina. Participants should be involved in programs like CSC, STEP, or similar community services. The study aims to include up to 50 individuals who can commit to a 6-month period.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Onboarding
Participants receive instructions and guidance for using the Altitudes platform
Treatment
Participants engage with the Altitudes digital platform, including psychoeducational and therapeutic content, for approximately 6 months
Follow-up
Participants are monitored for engagement and psychological status, well-being, and social support through self-report questionnaires
What Are the Treatments Tested in This Trial?
Interventions
- Altitudes
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
North Carolina Department of Health and Human Services
Collaborator